dibismuth trioxide
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
2
Earliest trial started Feb 1, 2015 (NCT03148366)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetBuffer
buffer
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dibismuth trioxide
- dibismuth trioxide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03555526 | Phase 4 | Dec 15, 2017 | National Taiwan University |
| NCT03208426 | Phase 4 | Oct 1, 2017 | National Taiwan University |
| NCT03148366 | Phase 3 | Feb 1, 2015 | National Taiwan University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Taiwan University | Academic/Hospital | 3 | 3 | 2 | 2015 |
1 organizations
Page 1 / 1